Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Dundee Corp T.DC.A

Alternate Symbol(s):  DDEJF | DNDEF | T.DC.PR.B | T.DC.PR.D | DNDPF

Dundee Corporation is a Canada-based holding company. Through its operating segments, the Company is a mining- focused investor primarily engaged in acquiring mineral resource assets. Its segments include Corporate and Other Portfolio Holdings; Goodman & Company, Investment Counsel Inc.; Dundee Sustainable Technologies Inc.; United Hydrocarbon International Corp., and Dundee 360 Real Estate... see more

TSX:DC.A - Post Discussion

Dundee Corp > Taurx Press from Genting
View:
Post by Catscratch on Jun 21, 2024 9:47am

Taurx Press from Genting

News article dated today with some comments from Genting on TauRx.

https://www.klsescreener.com/v2/news/view/1345595/genting-hopes-20-associate-taurx-s-alzheimer-s-drug-gets-approval-soon

"Meanwhile, Genting president and chief operating officer Datuk Seri Tan Kong Han said the process of acquiring approval for the drug approval is moving fast.

 

“We are quite ahead with MHRA (the Medicines and Healthcare products Regulatory Agency in the UK). With the FDA — which is [currently waiting] for their feedback. So the process is ongoing,” Tan said."

Comment by Macpoor on Jun 21, 2024 4:38pm
I was thinking what made DC.A up .19 cents this moring until , I see your post Catscratch.  Thank you for the news! Have a good weekend!
Comment by Catscratch on Jun 22, 2024 9:17am
Here's a clip from Genting's Chairman & CEO and President & COO on TauRx from yesterday:   https://youtu.be/Koz1Gq6g73M?si=ZrAdn5t2Zwb2z-qn
Comment by TheCount11 on Jun 23, 2024 3:19pm
Thanks for update!  Can't help but wonder why we don't get updates like this from Dundee? Macpoor do you think Dundee is in process of selling their TauRx? 
Comment by Macpoor on Jun 24, 2024 5:47am
Good morning TheCount11, Mr Goodman mentioned last week in the meeting that he is only interestd  in mining business.  I hope this message find your answer:))))
Comment by jrj90620 on Jun 24, 2024 2:27pm
What do you guys think DC should expect from it's Tau holding?The pie in the sky evaluation says that Tau could be worth $15billion,which means DC's 4% would be worth $600 million.I don't know.There is going to be a lot of competion coming.I'm thinking,if DC could get $75 million today,I would sell the Tau shares.But,I don't know what a fair valuation is today.
Comment by TheCount11 on Jun 24, 2024 11:01pm
Thanks Macpoor!
Comment by Catscratch on Jun 24, 2024 2:39pm
I don't there is really much new information here.  But I did find it encouraging to hear/see directly from TauRx's 20% owner that they think they are very close to approval from the UK regulator. At this point I think I'd prefer to see Dundee hold the investment until a firm regulatory decision is made.  Presumably if regulatory approval is received the valuation would be ...more  
Comment by TheCount11 on Jun 24, 2024 5:14pm
Yes.  Will be a blockbuster after approvals.  Depending how they price it will be one of the top 5 revenue grossing drugs and TauRx Inc could be worth 30 Billion USD (likely more).  Why?   There are currently no pills that treat Alzheimer's.  Eventually nearly everyone gets dimentia which makes the market huge.   1) Works for certain patients 2 ...more  
Comment by Catscratch on Jun 24, 2024 7:32pm
A valuation anywhere near $30B would be a great outcome.  Agree there are some significant benefits with HMTM including effectiveness, safety and easy of use...That said, not holding my breath.
Comment by TheCount11 on Jun 25, 2024 9:29am
Back in the day the industry would say "Cheapest Patient is a dead Patient" as NICE considered cost as well.  Getting regulatory approval from UK is a huge win.  As you know pretty much everyone is covered by some sort of government insurance once they are 65.  Every country.  Including US.  Imagine you or someone you love is suffiering from Alzheimers and you ...more  
Comment by Catscratch on Jun 25, 2024 12:01pm
Agree.  Once it's approved by a reputable western regulator others will follow.  I would expect TauRx to realize a significant valuation increase with the first major approval.
Comment by Macpoor on Jun 24, 2024 6:05am
Thank you Catscratch !
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities